Laboratory Corp. Of America Holdings (LH)

$222

+3.03

(+1.38%)▲

Market is closed - opens 8 PM, 05 Dec 2023

Insights on Laboratory Corp. Of America Holdings

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 3.03B → 3.05B (in $), with an average increase of 0.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 212.9M → 183.3M (in $), with an average decrease of 7.1% per quarter

  • Vs IDXX

    In the last 1 year, Idexx Laboratories, Inc. has given 10.9% return, outperforming this stock by 20.3%

Performance

  • $217.40
    $222.47
    $222.00
    downward going graph

    2.07%

    Downside

    Day's Volatility :2.28%

    Upside

    0.21%

    downward going graph
  • $194.34
    $255.55
    $222.00
    downward going graph

    12.46%

    Downside

    52 Weeks Volatility :23.95%

    Upside

    13.13%

    downward going graph

Returns

PeriodLaboratory Corp. Of America HoldingsSector (Health Care)S&P500
3 Months
7.1%
-1.3%
1.7%
6 Months
0.55%
1.2%
7.3%
1 Year
-7.37%
-5.7%
12.8%
3 Years
10.12%
17.1%
24.2%

Highlights

Market Capitalization
18.1B
Book Value
$92.73
Dividend Share
2.88
Dividend Yield
1.35%
Earnings Per Share (EPS)
9.7
PE Ratio
21.93
PEG Ratio
2.07
Wall Street Target Price
241.31
Profit Margin
4.39%
Operating Margin TTM
8.83%
Return On Assets TTM
5.33%
Return On Equity TTM
9.57%
Revenue TTM
15.1B
Revenue Per Share TTM
171.07
Quarterly Revenue Growth YOY
6.6000000000000005%
Gross Profit TTM
4.4B
EBITDA
2.1B
Diluted Eps TTM
9.7
Quarterly Earnings Growth YOY
-0.46
EPS Estimate Current Year
13.58
EPS Estimate Next Year
14.52
EPS Estimate Current Quarter
3.32
EPS Estimate Next Quarter
3.36

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 24 Wall street analysts offering stock ratings for Laboratory Corp. Of America Holdings(by analysts ranked 0 to 5 stars)
Based on 24 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
20
Hold
6
6
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 8.7%

Current $222.00
Target $241.31

Company Financials

FY17Y/Y Change
Revenue
10.4B
↑ 8.29%
Net Income
1.3B
↑ 73.23%
Net Profit Margin
12.15%
↑ 4.56%
FY18Y/Y Change
Revenue
11.3B
↑ 8.54%
Net Income
883.7M
↓ 30.32%
Net Profit Margin
7.8%
↓ 4.35%
FY19Y/Y Change
Revenue
11.6B
↑ 1.95%
Net Income
823.8M
↓ 6.78%
Net Profit Margin
7.13%
↓ 0.67%
FY20Y/Y Change
Revenue
14.0B
↑ 20.98%
Net Income
1.6B
↑ 88.89%
Net Profit Margin
11.13%
↑ 4.0%
FY21Y/Y Change
Revenue
16.1B
↑ 15.33%
Net Income
2.4B
↑ 52.77%
Net Profit Margin
14.75%
↑ 3.62%
FY22Y/Y Change
Revenue
14.9B
↓ 7.72%
Net Income
1.3B
↓ 46.2%
Net Profit Margin
8.6%
↓ 6.15%
Q2 FY22Q/Q Change
Revenue
3.7B
↓ 5.2%
Net Income
358.6M
↓ 27.05%
Net Profit Margin
9.7%
↓ 2.91%
Q3 FY22Q/Q Change
Revenue
3.6B
↓ 2.46%
Net Income
352.8M
↓ 1.62%
Net Profit Margin
9.78%
↑ 0.08%
Q4 FY22Q/Q Change
Revenue
3.7B
↑ 1.89%
Net Income
76.1M
↓ 78.43%
Net Profit Margin
2.07%
↓ 7.71%
Q1 FY23Q/Q Change
Revenue
3.8B
↑ 2.82%
Net Income
212.9M
↑ 179.76%
Net Profit Margin
5.64%
↑ 3.57%
Q2 FY23Q/Q Change
Revenue
3.0B
↓ 19.7%
Net Income
188.9M
↓ 11.27%
Net Profit Margin
6.23%
↑ 0.59%
Q3 FY23Q/Q Change
Revenue
3.1B
↑ 0.76%
Net Income
183.3M
↓ 2.96%
Net Profit Margin
6.0%
↓ 0.23%
FY17Y/Y Change
Total Assets
16.6B
↑ 16.29%
Total Liabilities
9.7B
↑ 11.4%
FY18Y/Y Change
Total Assets
16.2B
↓ 2.31%
Total Liabilities
9.2B
↓ 5.38%
FY19Y/Y Change
Total Assets
18.0B
↑ 11.34%
Total Liabilities
10.5B
↑ 13.46%
FY20Y/Y Change
Total Assets
20.1B
↑ 11.38%
Total Liabilities
10.7B
↑ 2.46%
FY21Y/Y Change
Total Assets
20.4B
↑ 1.56%
Total Liabilities
10.1B
↓ 5.6%
FY22Y/Y Change
Total Assets
20.2B
↓ 1.13%
Total Liabilities
10.1B
↓ 0.53%
Q2 FY22Q/Q Change
Total Assets
20.4B
↓ 1.57%
Total Liabilities
10.0B
↓ 0.05%
Q3 FY22Q/Q Change
Total Assets
19.8B
↓ 2.83%
Total Liabilities
9.7B
↓ 2.69%
Q4 FY22Q/Q Change
Total Assets
20.2B
↑ 1.66%
Total Liabilities
10.1B
↑ 3.34%
Q1 FY23Q/Q Change
Total Assets
20.2B
↑ 0.22%
Total Liabilities
9.8B
↓ 2.18%
Q2 FY23Q/Q Change
Total Assets
17.7B
↓ 12.35%
Total Liabilities
8.9B
↓ 9.4%
Q3 FY23Q/Q Change
Total Assets
16.9B
↓ 4.63%
Total Liabilities
9.0B
↑ 0.89%
FY17Y/Y Change
Operating Cash Flow
1.5B
↑ 24.11%
Investing Cash Flow
-2.2B
↑ 180.09%
Financing Cash Flow
631.9M
↓ 197.25%
FY18Y/Y Change
Operating Cash Flow
1.3B
↓ 10.55%
Investing Cash Flow
206.7M
↓ 109.27%
Financing Cash Flow
-1.4B
↓ 319.96%
FY19Y/Y Change
Operating Cash Flow
1.4B
↑ 10.67%
Investing Cash Flow
-1.3B
↓ 720.75%
Financing Cash Flow
-252.7M
↓ 81.82%
FY20Y/Y Change
Operating Cash Flow
2.1B
↑ 47.8%
Investing Cash Flow
-643.2M
↓ 49.87%
Financing Cash Flow
-517.4M
↑ 104.75%
FY21Y/Y Change
Operating Cash Flow
3.1B
↑ 45.63%
Investing Cash Flow
-884.6M
↑ 37.53%
Financing Cash Flow
-2.1B
↑ 299.27%
FY22Y/Y Change
Operating Cash Flow
2.0B
↓ 37.1%
Investing Cash Flow
-1.7B
↑ 86.77%
Financing Cash Flow
-1.3B
↓ 36.0%
Q2 FY22Q/Q Change
Operating Cash Flow
572.5M
↑ 60.81%
Investing Cash Flow
-242.5M
↓ 57.69%
Financing Cash Flow
-479.7M
↑ 2610.17%
Q3 FY22Q/Q Change
Operating Cash Flow
373.8M
↓ 34.71%
Investing Cash Flow
-563.3M
↑ 132.29%
Financing Cash Flow
-452.2M
↓ 5.73%
Q4 FY22Q/Q Change
Operating Cash Flow
653.6M
↑ 74.85%
Investing Cash Flow
-1.7B
↑ 193.31%
Financing Cash Flow
-372.6M
↓ 17.6%
Q1 FY23Q/Q Change
Operating Cash Flow
121.2M
↓ 81.46%
Investing Cash Flow
-99.7M
↓ 93.97%
Financing Cash Flow
-60.6M
↓ 83.74%
Q2 FY23Q/Q Change
Operating Cash Flow
351.4M
↑ 189.93%
Investing Cash Flow
-353.3M
↑ 254.36%
Financing Cash Flow
1.5B
↓ 2649.5%
Q3 FY23Q/Q Change
Operating Cash Flow
275.5M
↓ 21.6%
Investing Cash Flow
-840.9M
↑ 138.01%
Financing Cash Flow
-987.8M
↓ 163.94%

Technicals Summary

Sell

Neutral

Buy

Laboratory Corp. Of America Holdings is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Laboratory Corp. Of America Holdings
Laboratory Corp. Of America Holdings
4.5%
0.55%
-7.37%
10.12%
52.77%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
14.08%
3.72%
14.28%
5.57%
145.22%
Agilent Technologies Inc.
Agilent Technologies Inc.
19.77%
8.82%
-15.66%
11.85%
76.64%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
9.03%
-4.33%
-10.96%
4.53%
103.42%
Danaher Corp.
Danaher Corp.
14.3%
-4.14%
-16.6%
-0.42%
110.24%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
9.33%
6.32%
2.35%
27.14%
76.13%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Laboratory Corp. Of America Holdings
Laboratory Corp. Of America Holdings
21.93
21.93
2.07
13.58
0.1
0.05
0.01
92.73
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
48.79
48.79
7.21
9.84
0.93
0.24
0.01
15.62
Agilent Technologies Inc.
Agilent Technologies Inc.
33.15
33.15
2.36
5.41
0.22
0.08
0.01
20.01
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
32.16
32.16
4.28
21.56
0.13
0.05
0.0
117.32
Danaher Corp.
Danaher Corp.
27.92
27.92
3.24
7.55
0.12
0.05
0.0
70.93
Iqvia Holdings Inc.
Iqvia Holdings Inc.
35.36
35.36
1.48
10.19
0.2
0.05
0.0
31.81
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Laboratory Corp. Of America Holdings
Laboratory Corp. Of America Holdings
Buy
$18.1B
52.77%
21.93
4.39%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$39.7B
145.22%
48.79
22.93%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$37.0B
76.64%
33.15
18.15%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$189.6B
103.42%
32.16
13.68%
Danaher Corp.
Danaher Corp.
Buy
$163.6B
110.24%
27.92
20.01%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$38.5B
76.13%
35.36
7.51%

Institutional Holdings

  • BlackRock Inc

    13.99%

  • Vanguard Group Inc

    12.01%

  • State Street Corporation

    4.51%

  • Wellington Management Company LLP

    2.93%

  • Morgan Stanley - Brokerage Accounts

    2.61%

  • Geode Capital Management, LLC

    2.26%

Corporate Announcements

  • Laboratory Corp. Of America Holdings Dividends March,2023

    In the quarter ending March,2023. Laboratory Corp. Of America Holdings has declared dividend of $0.72

    Read More

Company Information

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.

Organization
Laboratory Corp. Of America Holdings
Employees
60000
CEO
Mr. Adam H. Schechter
Industry
Health Services

Discover More

FAQs